GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FDC Ltd (NSE:FDC) » Definitions » Capital Expenditure

FDC (NSE:FDC) Capital Expenditure : ₹0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is FDC Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

FDC's cash flow for capital expenditures for the three months ended in Sep. 2024 was ₹0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0.00 Mil.


FDC Capital Expenditure Historical Data

The historical data trend for FDC's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FDC Capital Expenditure Chart

FDC Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -312.33 -625.39 -1,325.44 -1,130.93 -933.93

FDC Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

FDC Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FDC Business Description

Traded in Other Exchanges
Address
106 A, J. P. Road, C-3 Skyvistas, D.N. Nagar, Near Versova Police Station, Andheri (West), Mumbai, MH, IND, 400053
FDC Ltd is principally engaged in the business of manufacturing and trading pharmaceutical products. It has its presence in numerous therapeutic segments including anti-infectives, gastrointestinal treatments, ophthalmics, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, and others. The company's different pharmaceutical products are marketed through brands such as Electral, Enerzal, Zifi, Zocon, Vitcofol, Otek Ac Neo, Amodep AT, Simyl MCT Oil, and many others. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and other regions.

FDC Headlines

From GuruFocus

Leon Cooperman on Surviving Fame and Infamy

By Robert Abbott Robert Abbott 01-31-2018

Steve Mandel Starts 3 New Positions in 3rd Quarter

By Sydnee Gatewood Sydnee Gatewood 11-29-2018

Leon Cooperman Buys 15.4 Million Shares of First Data

By David Goodloe David Goodloe 02-19-2016